“Cost-Effectiveness of Pioglitazone in Patients With Type 2 Diabetes and a History of Macrovascular Disease in a Swiss Setting”. Swiss Medical Weekly 139, no. 1112 (March 21, 2009): 173–173. Accessed November 3, 2025. https://smw.ch/index.php/smw/article/view/956.